- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07831265
Dynamic Fixation for Complex Ankle Fractures With Syndesmotic Diastasis.
A Prospective Randomized Controlled Trial of Dynamic Fixation for Complex Ankle Fractures With Syndesmotic Diastasis.
This prospective randomized controlled trial aims to evaluate the clinical effectiveness of dynamic fixation in patients with complex ankle fractures associated with syndesmotic diastasis.
Patients undergoing surgical treatment for complex ankle fractures with syndesmotic diastasis at Fujian Provincial Hospital Affiliated with Fuzhou University between October 2026 and October 2027 will be enrolled. Eligible participants will be randomly assigned in a 1:1 ratio to either the screw fixation (SF) group or the dynamic fixation (DF) group. All participants will be followed for 12 months after surgery. Clinical, functional, and radiographic outcomes will be compared between the two groups to assess the effectiveness and safety of dynamic fixation.
Statistical analyses will be performed using IBM SPSS Statistics version 27.0. The primary analysis will follow the intention-to-treat principle. Appropriate statistical methods will be selected according to the type and distribution of the data. Multivariable regression analyses will be performed when necessary to adjust for potential confounding factors. Missing data will be handled using multiple imputation where appropriate, and sensitivity analyses will be conducted to evaluate the robustness of the findings. All statistical tests will be two-sided, with a P<0.05 considered statistically significant.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: ZunLinCai
- Phone Number: 86+15345912057
- Email: 2893761828@qq.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18-55 years
- Radiologically confirmed complex ankle fracture combined with distal tibiofibular syndesmosis separation
- First-time surgical treatment of the ankle
- Time from injury to surgery ≤ 2 weeks
- Able to comply with follow-up and sign a written informed consent
- Ankle function was basically normal before injury
Exclusion Criteria:
- Age <18 or >55
- Pathological fracture
- Previous ankle surgery or serious primary ankle disease
- Time from injury to surgery >2 weeks
- Active infection or serious medical condition
- Severe neurological or psychiatric disorder affecting follow-up compliance
- Postmenopausal women
- Other situations not suitable for enrollment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: the screw fixation group
|
"Randomized controlled grouping was conducted under blind conditions, followed by treatment of complex ankle fractures with distal tibiofibular syndesmosis separation using screw fixation surgical methods. |
|
Experimental: the dynamic fixation group
|
Randomized controlled grouping was conducted under blind conditions, followed by treatment of complex ankle fractures with distal tibiofibular syndesmosis separation using dynamic internal fixation surgical methods. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The American Orthopaedic Foot and Ankle Society (AOFAS)
Time Frame: Preoperative; 1 week, 1 month, 3 months, 6 months, 1 year postoperative
|
The American Orthopaedic Foot and Ankle Society (AOFAS) , Ankle-Hindfoot Score ranges from a minimum of 0 to a maximum of 100, with higher scores indicating better ankle-hindfoot function and fewer symptoms. |
Preoperative; 1 week, 1 month, 3 months, 6 months, 1 year postoperative
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- K2026-09-013
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.